These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26934346)

  • 1. [How to choose the optimal therapy? New issues in the treatment of metastatic melanoma].
    Oláh J; Gyulai R
    Magy Onkol; 2016 Mar; 60(1):17-21. PubMed ID: 26934346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact immunotherapy enhances the therapeutic effects of nivolumab in treating in-transit melanoma: Two cases reports.
    Fujimura T; Furudate S; Kakizaki A; Kambayashi Y; Haga T; Hashimoto A; Aiba S
    J Dermatol; 2016 Jun; 43(6):686-9. PubMed ID: 26663262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatment of metastatic melanoma: new approaches.
    Hamid O; Boasberg PD; Rosenthal K; O'Day SJ
    J Surg Oncol; 2011 Sep; 104(4):425-9. PubMed ID: 21858838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Editorial].
    Schilling B; Schadendorf D
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):1-2. PubMed ID: 26713629
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy in melanoma: Recent advances and future directions.
    Franklin C; Livingstone E; Roesch A; Schilling B; Schadendorf D
    Eur J Surg Oncol; 2017 Mar; 43(3):604-611. PubMed ID: 27769635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on immunotherapy in melanoma.
    Green J; Ariyan C
    Surg Oncol Clin N Am; 2015 Apr; 24(2):337-46. PubMed ID: 25769716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.
    Levine O; Devji T; Xie F
    Immunotherapy; 2017 Mar; 9(5):375-378. PubMed ID: 28357918
    [No Abstract]   [Full Text] [Related]  

  • 8. Current and future roles of targeted therapy and immunotherapy in advanced melanoma.
    Olszanski AJ
    J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapies and melanoma].
    Routier É; Robert C; Mateus C
    Bull Cancer; 2014 Dec; 101 Suppl 2():S13-24. PubMed ID: 25776763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipilimumab in advanced melanoma: reports of long-lasting responses.
    Farolfi A; Ridolfi L; Guidoboni M; Nicoletti SV; Piciucchi S; Valmorri L; Costantini M; Scarpi E; Amadori D; Ridolfi R
    Melanoma Res; 2012 Jun; 22(3):263-70. PubMed ID: 22516968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Therapeutic Landscape of Advanced Melanoma.
    Henriques V; Martins T; Link W; Ferreira BI
    Curr Pharm Des; 2018; 24(5):549-558. PubMed ID: 29366407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma.
    Franke V; van der Hiel B; van de Wiel BA; Klop WMC; Ter Meulen S; van Akkooi ACJ
    Eur J Cancer; 2018 Feb; 90():149-152. PubMed ID: 29224902
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
    Zigler M; Villares GJ; Lev DC; Melnikova VO; Bar-Eli M
    Am J Clin Dermatol; 2008; 9(5):307-11. PubMed ID: 18717605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications and options for systemic therapy in melanoma.
    Sondak VK; Gibney GT
    Surg Clin North Am; 2014 Oct; 94(5):1049-58, viii. PubMed ID: 25245967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma: from darkness to promise.
    Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
    Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Despite past disappointments, the future of melanoma therapy appears bright.
    Tarhini A
    Oncology (Williston Park); 2009 May; 23(6):509, 515. PubMed ID: 19544692
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy for advanced melanoma: fulfilling the promise.
    Gogas H; Polyzos A; Kirkwood J
    Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of melanoma: efficacy and mode of action.
    Wieder T; Brenner E; Braumüller H; Röcken M
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):28-37. PubMed ID: 26713633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.